Quarterly report [Sections 13 or 15(d)]

EQUITY (Tables)

v3.26.3
EQUITY (Tables)
9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Schedule of Warrants Outstanding and Exercisable The following table summarizes the status of warrants and related transactions:
Non-Derivative (Equity) Warrants
Derivative Liabilities Warrants
Total Number of Warrants Weighted - Average Exercise Price
Balance as of January 1, 2026
57,994,087 21,400,000 79,394,087 $ 0.95 
Granted 100,000  —  100,000  $ 0.48 
Balance as of September 30, 2026
58,094,087 21,400,000 79,494,087 $ 0.95 
Exercisable as of September 30, 2026
56,874,087 21,400,000 78,274,087 $ 0.95 
Schedule of Share-Based Payment Award, Warrants, Valuation Assumptions The following assumptions were used for the calculation at date of issuance:
Weighted average stock price $0.49
Weighted average expected stock price volatility 106.4%
Expected annual dividend yield 0%
Weighted average expected life of warrants
5.0 years
Weighted average risk-free annual interest rate 4.2%
Weighted average grant date fair value $0.39
Schedule of Stock Options Outstanding
The following table summarizes the status of stock options and related transactions:
Number of Stock Options Weighted-Average Per Share Exercise Price
Issued and Outstanding as of January 1, 2026 26,597,918  $ 0.75 
Granted 635,000  $ 0.52 
Exercised
(11,666) $ 0.46 
Cancelled/forfeited/expired (200,000) $ 0.64 
Issued and Outstanding as of September 30, 2026 27,021,252  $ 0.74 
Exercisable as of September 30, 2026 21,261,558  $ 0.80 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The following assumptions were used for the calculation at date of grant:
Nine Months Ended September 30,
2026 2025
Weighted average stock price $0.52 $0.41
Weighted average expected stock price volatility 104.1% 92.8%
Expected annual dividend yield 0% 0%
Weighted average expected life 5.4 years 5.1 years
Weighted average risk-free annual interest rate 4.5% 3.9%
Weighted average grant date fair value $0.41 $0.30
Schedule of Components of Share-based Compensation Expense
The components of share-based compensation expense, net, are as follows:
Three Months Ended September 30, Nine Months Ended September 30,
2026 2025 2026 2025
Stock options expense $ 227  $ 261  $ 747  $ 187 
Restricted stock —  —  68  — 
Warrants 60  96  176  237 
Total share-based compensation expense, net $ 287  $ 357  $ 991  $ 424